Desq Long
Sign in

Company

Summit Therapeutics Inc.

SMMT · CIK 0001599298

SEC FORM 4
$0.00

Summit Therapeutics Inc. (SMMT)

Acquisition (code A) of 100,000 shares at $0 per share.

Reporting Person Anand Bhaskar · Officer Title Chief Accounting Officer · Transaction Code A

Traded Oct 8, 2026 · Disclosed Oct 14, 2026FILED +6 DAYS

Source: SEC Form 4 · 0001890784-26-000006 · filed 2026-10-14 · View filing →